United States

Lotus Pharmaceuticals Inc (LTUS.OB)

Track

Ticker: LTUS.OB
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Jin Liu Non-Executive Director
Transaction date
Sale
Price
308.19
Quantity 40,149 +42.8%
Value US$3,894,610
ROTHBERG MELVIN Non-Executive Director
Transaction date
Sale
Price
315.14
Quantity 69,015 +17.4%
Value US$4,210,766
GENESIS TECHNOLOGY GROUP INC Large shareholder
Transaction date
Sale
Price
461.20
Quantity 27,351 -6.4%
Value US$3,882,660
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-07-01 2010-06-28 S Sale Jin Liu Non-Executive Director
40,149 +42.8%
308.19
US$3,894,610 		40,149 +42.8% 308.19 US$3,894,610
2008-01-09 2008-01-02 S Sale ROTHBERG MELVIN Non-Executive Director
69,015 +17.4%
315.14
US$4,210,766 		69,015 +17.4% 315.14 US$4,210,766
2007-08-09 2007-08-06 S Sale GENESIS TECHNOLOGY GROUP INC Large shareholder
27,351 -6.4%
461.20
US$3,882,660 		27,351 -6.4% 461.20 US$3,882,660
Explore more

More insider trading research around Lotus Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America